These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1292 related articles for article (PubMed ID: 19451802)

  • 1. High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor.
    Deng Y; Kurland BF; Wang J; Bi J; Li W; Rao S; Lan P; Lin T; Lin E
    Am J Clin Oncol; 2009 Jun; 32(3):245-52. PubMed ID: 19451802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
    Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
    Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors.
    De Jong KP; Stellema R; Karrenbeld A; Koudstaal J; Gouw AS; Sluiter WJ; Peeters PM; Slooff MJ; De Vries EG
    Hepatology; 1998 Oct; 28(4):971-9. PubMed ID: 9755233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor receptor (EGFR) status in primary colorectal tumors does not correlate with EGFR expression in related metastatic sites: implications for treatment with EGFR-targeted monoclonal antibodies.
    Scartozzi M; Bearzi I; Berardi R; Mandolesi A; Fabris G; Cascinu S
    J Clin Oncol; 2004 Dec; 22(23):4772-8. PubMed ID: 15570078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up.
    Theodoropoulos GE; Karafoka E; Papailiou JG; Stamopoulos P; Zambirinis CP; Bramis K; Panoussopoulos SG; Leandros E; Bramis J
    Anticancer Res; 2009 Feb; 29(2):785-91. PubMed ID: 19331236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of p16 in lymph node metastases of adjuvantly treated stage III colorectal cancer patients identifies poor prognostic subgroups: a retrospective analysis of biomarkers in matched primary tumor and lymph node metastases.
    Karamitopoulou E; Zlobec I; Koumarianou A; Patsouris ES; Peros G; Lugli A
    Cancer; 2010 Oct; 116(19):4474-86. PubMed ID: 20572035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coexpression of VEGF-C and Cox-2 in human colorectal cancer and its association with lymph node metastasis.
    Soumaoro LT; Uetake H; Takagi Y; Iida S; Higuchi T; Yasuno M; Enomoto M; Sugihara K
    Dis Colon Rectum; 2006 Mar; 49(3):392-8. PubMed ID: 16474989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor expression in metastatic pulmonary tumor from colorectal carcinoma: utility as a prognostic factor.
    Tamura M; Oda M; Tsunezuka Y; Matsumoto I; Kawakami K; Watanabe G
    J Thorac Cardiovasc Surg; 2004 Oct; 128(4):517-22. PubMed ID: 15457151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation.
    Muller S; Su L; Tighiouart M; Saba N; Zhang H; Shin DM; Chen Z
    Cancer; 2008 Jul; 113(1):97-107. PubMed ID: 18473353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma.
    Paik SS; Jang SM; Jang KS; Lee KH; Choi D; Jang SJ
    Ann Surg Oncol; 2009 Feb; 16(2):297-303. PubMed ID: 19050975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of epidermal growth factor receptor and vascular endothelial growth factor receptor in colorectal adenocarcinoma.
    Kim JY; Bae BN; Kwon JE; Kim HJ; Park K
    APMIS; 2011 Jul; 119(7):449-59. PubMed ID: 21635552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human epidermal growth factor receptor-2 family in colorectal adenocarcinoma: correlation with survival and clinicopathological findings.
    Molaei M; Pejhan S; Nayer BN; Moradi A; Ghiasi S; Zali MR
    Eur J Gastroenterol Hepatol; 2009 Mar; 21(3):289-93. PubMed ID: 19279475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue microarray analysis of 560 patients with colorectal adenocarcinoma: high expression of HuR predicts poor survival.
    Yoo PS; Sullivan CA; Kiang S; Gao W; Uchio EM; Chung GG; Cha CH
    Ann Surg Oncol; 2009 Jan; 16(1):200-7. PubMed ID: 19009247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intense cytoplasmic ezrin immunoreactivity predicts poor survival in colorectal cancer.
    Elzagheid A; Korkeila E; Bendardaf R; Buhmeida A; Heikkilä S; Vaheri A; Syrjänen K; Pyrhönen S; Carpén O
    Hum Pathol; 2008 Dec; 39(12):1737-43. PubMed ID: 18701134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
    Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of insulin-like growth factor-2, c-MET, matrix metalloproteinase-7 and MUC-1 in primary lesions and lymph node metastatic lesions of gastric cancer.
    Ajisaka H; Fushida S; Yonemura Y; Miwa K
    Hepatogastroenterology; 2001; 48(42):1788-92. PubMed ID: 11813625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topoisomerase I protein expression in primary colorectal cancer and lymph node metastases.
    Boonsong A; Curran S; McKay JA; Cassidy J; Murray GI; McLeod HL
    Hum Pathol; 2002 Nov; 33(11):1114-9. PubMed ID: 12454816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced expression of Apaf-1 in colorectal adenocarcinoma correlates with tumor progression and aggressive phenotype.
    Paik SS; Jang KS; Song YS; Jang SH; Min KW; Han HX; Na W; Lee KH; Choi D; Jang SJ
    Ann Surg Oncol; 2007 Dec; 14(12):3453-9. PubMed ID: 17882496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy.
    Chua DT; Nicholls JM; Sham JS; Au GK
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):11-20. PubMed ID: 15093894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of VEGF expression evaluated by quantitative immunohistochemical analysis in colorectal cancer.
    Zafirellis K; Agrogiannis G; Zachaki A; Gravani K; Karameris A; Kombouras C
    J Surg Res; 2008 Jun; 147(1):99-107. PubMed ID: 17655863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 65.